非大量饮酒与非酒精性脂肪性肝病无创纤维化标志物恶化:一项队列研究
在58,927名纤维化评分低的韩国非酒精性脂肪性肝病成人中随访中位4.9年,评估非大量饮酒与无创纤维化指标恶化的关联。轻度和中度饮酒者FIB-4恶化的多变量校正HR分别为1.06(0.98-1.16)和1.29(1.18-1.40),NFS对应HR为1.09(1.02-1.16)和1.31(1.23-1.40)。结论认为非大量饮酒尤其是中度饮酒与纤维化无创标志物恶化显著独立相关,即使中度饮酒也可能有害。
要点
- 在低纤维化评分的非酒精性脂肪性肝病成人中,中度饮酒与FIB-4恶化独立相关,HR 1.29(95%CI 1.18-1.40)。
- 中度饮酒与NFS恶化独立相关,HR 1.31(95%CI 1.23-1.40)。
- 轻度饮酒与FIB-4恶化无显著关联,HR 1.06(95%CI 0.98-1.16);与NFS恶化关联HR 1.09(95%CI 1.02-1.16)。
核心结论
- 在年轻和中年非酒精性脂肪性肝病人群中,非大量饮酒尤其是中度饮酒与无创纤维化标志物恶化显著且独立相关,提示即使中度饮酒也可能有害。
研究设计与样本
- 在58,927名纤维化评分低的韩国非酒精性脂肪性肝病成人中开展队列研究,随访中位4.9年。
- 非饮酒、轻度饮酒和中度饮酒分别定义为0 g/天、1-9.9 g/天和10-29.9 g/天(女性为10-19.9 g/天)。
- 使用NAFLD纤维化评分(NFS)和Fibrosis-4指数(FIB-4)评估从低概率进展至中或高概率晚期纤维化,采用参数比例风险模型估计多变量校正HR和95%CI。
主要发现
- 随访347,925.4人年期间,5,630名低FIB-4受试者进展为中或高FIB-4。
- 与不饮酒者相比,轻度饮酒者和中度饮酒者FIB-4恶化的多变量校正HR(95%CI)分别为1.06(0.98-1.16)和1.29(1.18-1.40)。
- 使用NFS时,与不饮酒者相比,轻度饮酒者和中度饮酒者对应的HR(95%CI)分别为1.09(1.02-1.16)和1.31(1.23-1.40)。
- 将饮酒和混杂因素作为时变协变量引入后,中度饮酒与FIB-4或NFS恶化的关联仍显著。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
The effect of modest alcohol consumption on fibrosis progression in the general population with nonalcoholic fatty liver disease (NAFLD) remains unclear. We examined the association of nonheavy alcohol consumption with worsening of noninvasive fibrosis indices in a large-scale, low-risk population with NAFLD. A cohort study was performed in 58,927 Korean adults with NAFLD and low fibrosis scores who were followed for a median of 4.9 years. Non-, light, and moderate drinkers were defined as 0 g/day, 1-9.9 g/day, and 10-29.9 g/day (10-19.9 g/day for women), respectively. Progression from low to intermediate or high probability of advanced fibrosis was assessed using noninvasive indices including NAFLD fibrosis score (NFS) and Fibrosis-4 Index (FIB-4). A parametric proportional hazards model was used to estimate the multivariable-adjusted hazard ratios (HRs) and 95% confidence intervals (CIs). During 347,925.4 person-years of follow-up, 5,630 subjects with low FIB-4 progressed to intermediate or high FIB-4. The multivariable-adjusted HRs (95% CI) for worsening of FIB-4 comparing light and moderate drinkers with nondrinkers were 1.06 (0.98-1.16) and 1.29 (1.18-1.40), respectively. Similarly, using NFS, corresponding HRs (95% CI) comparing light and moderate drinkers with nondrinkers were 1.09 (1.02-1.16) and 1.31 (1.23-1.40), respectively. Furthermore, the association of moderate drinkers with worsening of either FIB-4 or NFS remained significant after introducing alcohol use and confounders treated as time-varying covariates. Conclusion: In this large-scale cohort of young and middle-aged individuals with NAFLD, nonheavy alcohol consumption, especially moderate alcohol consumption, was significantly and independently associated with worsening of noninvasive markers of fibrosis, indicating that even moderate alcohol consumption might be harmful.
引用
- Chang Y, Cho YK, Kim Y, et al. Nonheavy Drinking and Worsening of Noninvasive Fibrosis Markers in Nonalcoholic Fatty Liver Disease: A Cohort Study. Hepatology. 2018. PMID: 30019340. doi:10.1002/hep.30170
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。